The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers

Breast Cancer Research and Treatment

Volumn 130, Issue 3, 2011, Pages 897-904

  Brewster, A M ^a   Etzel, C ^a   Zhou, R ^a   Wong, Y ^b   Edge, S ^c   Blayney, D W ^d   Wilson, J ^e   Hudis, C ^f   Ottesen, R ^g   Hughes, M E ^h   Weeks, J C ^h   Theriault, R L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d STANFORD CANCER INSTITUTE   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^h DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Adjuvant; Breast neoplasms; Chemotherapy; Healthcare Disparities; Obesity; Standard of care

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; COMORBIDITY; CONTROLLED STUDY; DRUG INDICATION; DRUG USE; ETHNICITY; FEMALE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; NEGRO; OBESITY; ONSET AGE; PRESCRIPTION; PRIORITY JOURNAL;

ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OBESITY;

EID: 82255186329     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1516-0     Document Type: Article

References (33)

1. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687-1717
2. SH Giordano GN Hortobagyi SW Kau RL Theriault ML Bondy 2005 Breast cancer treatment guidelines in older women J Clin Oncol 23 4 783 791 15681522 10.1200/JCO.2005.04.175 (Pubitemid 46224177)
3. JJ Griggs E Culakova ME Sorbero MS Poniewierski DA Wolff J Crawford DC Dale GH Lyman 2007 Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens J Clin Oncol 25 18 2522 2527 17577029 10.1200/JCO.2006.10.2749 (Pubitemid 47041224)
4. LC Harlan AL Greene LX Clegg M Mooney JL Stevens ML Brown 2005 Insurance status and the use of guideline therapy in the treatment of selected cancers J Clin Oncol 23 36 9079 9088 16301598 10.1200/JCO.2004.00.1297
5. X Du JS Goodwin 2001 Patterns of use of chemotherapy for breast cancer in older women: findings from medicare claims data J Clin Oncol 19 5 1455 1461 11230491 1:STN:280:DC%2BD3M7osVGrug%3D%3D (Pubitemid 32202553)
6. A Bhargava XL Du 2009 Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer Cancer 115 13 2999 3008 19452539 10.1002/cncr.24363
7. VL Shavers LC Harlan JL Stevens 2003 Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35 Cancer 97 1 134 147 12491515 10.1002/cncr.11051 (Pubitemid 36033873)
8. J White M Morrow J Moughan J Owen T Pajak S DesHarnais DP Winchester JF Wilson 2003 Compliance with breast-conservation standards for patients with early-stage breast carcinoma Cancer 97 4 893 904 12569588 10.1002/cncr.11141 (Pubitemid 36173140)
9. NA Bickell JJ Wang S Oluwole D Schrag H Godfrey K Hiotis J Mendez AA Guth 2006 Missed opportunities: racial disparities in adjuvant breast cancer treatment J Clin Oncol 24 9 1357 1362 16549830 10.1200/JCO.2005.04.5799 (Pubitemid 46621998)
10. A DeMichele M Putt Y Zhang JH Glick S Norman 2003 Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients Cancer 97 9 2150 2159 12712466 10.1002/cncr.11338 (Pubitemid 36444055)
11. CI Li KE Malone JR Daling 2003 Differences in breast cancer stage, treatment, and survival by race and ethnicity Arch Intern Med 163 1 49 56 12523916 10.1001/archinte.163.1.49 (Pubitemid 36091600)
12. RA Freedman KS Virgo Y He AL Pavluck EP Winer EM Ward NL Keating 2010 The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care Cancer 117 1 180 189 20939011 10.1002/cncr.25542
13. A Naeim A Hurria B Leake RC Maly 2006 Do age and ethnicity predict breast cancer treatment received? A cross-sectional urban population based study. Breast cancer treatment: age and ethnicity Crit Rev Oncol Hematol 59 3 234 242 16829122 10.1016/j.critrevonc.2006.03.002 (Pubitemid 44403959)
14. JS Haas CC Earle JE Orav P Brawarsky M Keohane BA Neville DR Williams 2008 Racial segregation and disparities in breast cancer care and mortality Cancer 113 8 2166 2172 18798230 10.1002/cncr.23828
15. KM Flegal MD Carroll CL Ogden LR Curtin 2010 Prevalence and trends in obesity among US adults, 1999-2008 JAMA 303 3 235 241 20071471 10.1001/jama.2009.2014 1:CAS:528:DC%2BC3cXptVyksA%3D%3D
16. M Colleoni S Li RD Gelber KN Price AS Coates M Castiglione-Gertsch A Goldhirsch 2005 Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index Lancet 366 9491 1108 1110 16182899 10.1016/S0140-6736(05)67110-3 1:CAS:528:DC%2BD2MXhtVartLrN (Pubitemid 41338765)
17. JJ Griggs ME Sorbero GH Lyman 2005 Undertreatment of obese women receiving breast cancer chemotherapy Arch Intern Med 165 11 1267 1273 15956006 10.1001/archinte.165.11.1267 (Pubitemid 40989591)
18. Y Madarnas CA Sawka E Franssen GA Bjarnason 2001 Are medical oncologists biased in their treatment of the large woman with breast cancer? Breast Cancer Res Treat 66 2 123 133 11437098 10.1023/A:1010635328299 1:STN:280: DC%2BD3MzotVWlsw%3D%3D (Pubitemid 32521418)
19. GL Rosner JB Hargis DR Hollis DR Budman RB Weiss IC Henderson RL Schilsky 1996 Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541 J Clin Oncol 14 11 3000 3008 8918498 1:CAS:528:DyaK2sXhsVKn (Pubitemid 26371459)
20. DS Buist L Ichikawa MN Prout MU Yood TS Field C Owusu AM Geiger VP Quinn F Wei RA Silliman 2007 Receipt of appropriate primary breast cancer therapy and adjuvant therapy are not associated with obesity in older women with access to health care J Clin Oncol 25 23 3428 3436 17687148 10.1200/JCO.2007.11.4918 (Pubitemid 47310879)
21. J Delva PM O'Malley LD Johnston 2006 Racial/ethnic and socioeconomic status differences in overweight and health-related behaviors among American students: national trends 1986-2003 J Adolesc Health 39 4 536 545 16982389 10.1016/j.jadohealth.2006.02.013 (Pubitemid 44375033)
22. D Kim SV Subramanian SL Gortmaker I Kawachi 2006 US state- and county-level social capital in relation to obesity and physical inactivity: a multilevel, multivariable analysis Soc Sci Med 63 4 1045 1059 16644081 10.1016/j.socscimed.2006.02.017
23. A Amarasinghe G D'Souza C Brown H Oh T Borisova 2009 The influence of socioeconomic and environmental determinants on health and obesity: a West Virginia case study Int J Environ Res Public Health 6 8 2271 2287 19742160 10.3390/ijerph6082271
24. TW Yen HM Kuerer RA Ottesen L Rouse JC Niland SB Edge RL Theriault JC Weeks 2007 Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ J Clin Oncol 25 22 3251 3258 17577019 10.1200/JCO.2006.10.2699 1:CAS:528:DC%2BD2sXhtVWqs7vK (Pubitemid 47325609)
25. ME Charlson P Pompei KL Ales CR MacKenzie 1987 A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 5 373 383 3558716 10.1016/0021-9681(87)90171-8 1:STN:280:DyaL2s7ms1GnsQ%3D%3D (Pubitemid 17055592)
26. JN Katz LC Chang O Sangha AH Fossel DW Bates 1996 Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34 1 73 84 8551813 10.1097/00005650-199601000-00006 1:STN:280:DyaK287kt1eisw%3D%3D (Pubitemid 126433198)
27. (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health. Obes Res 6(Suppl 2): 51S-209S
28. MA Gerend M Pai 2008 Social determinants of black-white disparities in breast cancer mortality: a review Cancer Epidemiol Biomarkers Prev 17 11 2913 2923 18990731 10.1158/1055-9965.EPI-07-0633
29. MJ Hassett JJ Griggs 2009 Disparities in breast cancer adjuvant chemotherapy: moving beyond yes or no J Clin Oncol 27 13 2120 2121 19307493 10.1200/JCO.2008.21.1532
30. RJ Hunter MA Navo PH Thaker DC Bodurka JK Wolf JA Smith 2009 Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA) Cancer Treat Rev 35 1 69 78 18922643 10.1016/j.ctrv.2008.07.005 1:CAS:528:DC%2BD1MXhtlSmuro%3D
31. CG Greenman CH Jagielski JJ Griggs 2008 Breast cancer adjuvant chemotherapy dosing in obese patients: dissemination of information from clinical trials to clinical practice Cancer 112 10 2159 2165 18338813 10.1002/cncr.23416 1:CAS:528:DC%2BD1cXmt1Cns7o%3D (Pubitemid 351628624)
32. M Protani M Coory JH Martin 2010 Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis Breast Cancer Res Treat 123 3 627 635 20571870 10.1007/s10549-010-0990-0
33. M Ewertz MB Jensen KA Gunnarsdottir I Hojris EH Jakobsen D Nielsen LE Stenbygaard UB Tange S Cold 2010 Effect of obesity on prognosis after early-stage breast cancer J Clin Oncol 29 1 25 31 21115856 10.1200/JCO.2010.29. 7614